N-甲基丙二酸单乙酯单酰胺 | 71510-95-7

• 物质功能分类: 有机原料 - 氨基化合物 - 酰胺类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: N-甲基丙二酸单乙酯单酰胺
• 中文别名: 丙二醇单乙酯甲酰胺
• 英文名称: 2-carboethoxy-N-methyl-acetamide
• 英文别名: 3-(methylamino)-3-oxopropionic acid ethyl ester；ethyl 3-(methylamino)-3-oxopropanoate；ethyl 3-(methylamino)-3-oxopopanoate；N-metiletossicarbonilacetammide；monoformamide monoethyl ester；ethyl-N-methylmalonamide
• CAS: 71510-95-7
• 化学式: C₆H₁₁NO₃
• mdl: MFCD08458724
• 分子量: 145.158
• InChiKey: VWTRXRCWWIJCCQ-UHFFFAOYSA-N

物化性质

• 熔点：
  34-35 °C(Solv: cyclohexane (110-82-7))
• 沸点：
  91-92 °C(Press: 0.16 Torr)
• 密度：
  1.059±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少量）、DMSO（少量）、甲醇（非常少量）

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2924199090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Ethyl-n-methyl malonamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Ethyl-n-methyl malonamide
CAS number: 71510-95-7

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H11NO3
Molecular weight: 145.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  N-甲基丙二酸单乙酯单酰胺 以 异丙醇 、 mineral oil 为溶剂， 以82%的产率得到2-carboisopropoxy-N-methyl-acetamide
  参考文献：
  名称：

  Process for the preparation of 3-substituted 4-phenyl-piperidine derivative

  摘要：

  本发明描述了制备公式(I)中3-取代的4-苯基哌啶衍生物的过程 其中X选自H和F，R选自由H、C1-C6烷基、C3-C6烯基和苄基组成的组，包括从马来酸单酰胺和肉桂醛或其衍生物开始的三个步骤。

  公开号：

  US06444822B1
• 作为产物：
  描述：

  氯甲酰乙酸乙酯 、 甲胺 以 水 为溶剂， 生成 N-甲基丙二酸单乙酯单酰胺
  参考文献：
  名称：

  Base-Catalyzed Ring Opening of N-Substituted 5-Isoxazolones¹

  摘要：

  DOI：

  10.1021/jo01053a062

文献信息

• Piperazine and homopiperazine compounds
  申请人：Millennium Pharmaceuticals, Inc.

  公开号：US20030153556A1

  公开（公告）日：2003-08-14

  Compounds are provided having a piperazine or homopiperazine ring which are useful in the treatment of thrombosis.

  提供了具有哌嗪或同源哌嗪环的化合物，这些化合物在治疗血栓症方面很有用。
• [EN] SUBSTITUTED HETEROARYL COMPOUNDS AND METHODS OF USE<br/>[FR] COMPOSÉS HÉTÉROARYLE SUBSTITUÉS ET LEURS MÉTHODES D'UTILISATION
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2019099311A1

  公开（公告）日：2019-05-23

  The present invention provides novel heteroaryl compounds, pharmaceutical acceptable salts and formulations thereof. They are useful in preventing, managing, treating or lessening the severity of a protein kinase-mediated disease. The invention also provides pharmaceutically acceptable compositions comprising such compounds and methods of using the compositions in the treatment of protein kinase-mediated disease.

  本发明提供了新颖的杂环芳基化合物，其药用盐和制剂。它们在预防、管理、治疗或减轻蛋白激酶介导的疾病的严重程度方面是有用的。该发明还提供了包括这些化合物的药用组合物以及使用这些组合物治疗蛋白激酶介导的疾病的方法。
• 取代的杂芳基化合物及其组合物和用途
  申请人：广东东阳光药业有限公司

  公开号：CN109776522B

  公开（公告）日：2020-12-29

  本发明公开了取代的杂芳基化合物及其组合物和它们的用途。所述化合物为式(I)所示的化合物或者式(I)所示化合物的立体异构体、互变异构体、氮氧化物、溶剂化物、代谢产物、药学上可接受的盐或它的前药。本发明还提供了包含所述化合物的药物组合物，所述化合物和药物组合物可以调节蛋白激酶，尤其是Aurora激酶和JAK激酶的活性，用于预防、处理、治疗和减轻蛋白激酶，尤其是JAK激酶活性介导的疾病或紊乱。
• NOVEL 6-5 BICYCIC HETEROCYCLIC DERIVATIVE AND MEDICAL USE THEREOF
  申请人：Sanwa Kagaku Kenkyusho Co., Ltd

  公开号：EP2036887A1

  公开（公告）日：2009-03-18

  An object of the present invention is to provide a medicament as a thyroid hormone receptor ligand which is sufficient in drug efficacy and safety, and has the excellent action as a drug. The present invention provides a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: [wherein [Chemical Formula 2] is a single bond or a double bond; A is -CH2- or -CO-; X, Y, and Z are each independently a nitrogen atom or a carbon atom; R1 is a hydrogen atom or an aralkyl group; R2 is an alkyl group or an aralkyl group, etc.; R3 is a hydrogen atom or an alkyl group, etc.; R4 is a hydrogen atom or an alkyl group; R5 is a hydrogen atom, an alkyl group or a halo lower alkyl group, etc.; R6 is a hydrogen atom or an alkyl group; R7 is a hydrogen atom, etc.; R8 is a hydrogen atom, or an alkyl group, etc.; and E is -NHCO-G-COR12, etc. (wherein G is a single bond or an alkylene group, and R12 is a hydroxy group or an alkoxy group)].

  本发明的目的是提供一种药物，作为甲状腺激素受体配体，其在药物疗效和安全性上足够，并且具有作为药物的优秀作用。本发明提供了一种由以下通式（I）表示的化合物或其药用可接受的盐：[其中[化学公式2]是单键或双键；A是-CH2-或-CO-；X、Y和Z各自独立为氮原子或碳原子；R1是氢原子或芳烷基团；R2是烷基团或芳烷基团等；R3是氢原子或烷基团等；R4是氢原子或烷基团；R5是氢原子、烷基团或卤素低烷基团等；R6是氢原子或烷基团；R7是氢原子等；R8是氢原子或烷基团等；E是-NHCO-G-COR12等（其中G是单键或亚烷基团，R12是羟基或烷氧基）]。
• Hydroalkylation of Unactivated Olefins via Visible-Light-Driven Dual Hydrogen Atom Transfer Catalysis
  作者：Guangyue Lei、Meichen Xu、Rui Chang、Ignacio Funes-Ardoiz、Juntao Ye

  DOI：10.1021/jacs.1c05852

  日期：2021.7.28

  hydroalkylation of olefins enabled by hydrogen atom transfer (HAT) catalysis represents a straightforward means to access C(sp3)-rich molecules from abundant feedstock chemicals without the need for prefunctionalization. While Giese-type hydroalkylation of activated olefins initiated by HAT of hydridic carbon–hydrogen bonds is well-precedented, hydroalkylation of unactivated olefins in a similar fashion

  通过氢原子转移 (HAT) 催化实现的烯烃自由基加氢烷基化代表了一种直接获得 C( sp 3)-丰富的分子来自丰富的原料化学品，无需预官能化。虽然由氢化碳-氢键的 HAT 引发的活性烯烃的 Giese 型加氢烷基化是有先例的，但未活化烯烃以类似方式的加氢烷基化仍然难以捉摸，主要是由于缺乏克服固有极性不匹配的通用方法。设想。在这里，我们报告了使用可见光驱动的双 HAT 催化来实现这一目标，其中催化量的胺硼烷和原位生成的硫醇分别用作氢原子提取物和供体。该反应是完全原子经济的，具有广泛的范围。